Atlas Trials

Ardelyx

29 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Ardelyx

RecordFirmDate
A 26-Wk Study to Assess Safety & Efficacy of Tenapanor for T/t of Chronic Idiopathic Constipation in Adults (NCT07382167)Ardelyx2026-01-13
4-Week, Multi-center Dose-Ranging Study for the IBS-C in Pts. 6 to <12 Yrs (NCT06553547)Ardelyx2024-07-24
An Open-label Study to Evaluate the Pharmacokinetics of Oral Tenapanor in Breast Milk of Lactating Females (NCT06203444)Ardelyx2023-11-27
Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C (NCT05905926)Ardelyx2023-02-17
Study to Assess Safety and Efficacy of Tenapanor for Treatment of IBS-C in Pediatric Patients 12 to Less Than 18 Years (NCT05643534)Ardelyx2022-11-15
Study to Evaluate the Use of Tenapanor as Core Therapy in the Treatment of Hyperphosphatemia (NCT04549597)Ardelyx2020-11-20
A Long-Term Study of Tenapanor Alone or in Combination With Sevelamer in Patients With CKD on Dialysis and HP (NCT03988920)Ardelyx2019-06-15
Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder Therapy (NCT03824587)Ardelyx2019-02-28
A Phase 3 Study of Tenapanor to Treat Hyperphosphatemia in ESRD Patients on Dialysis (NCT03427125)Ardelyx2018-01-08

Track Ardelyx automatically

Every clearance here is in the API, with alerts when new ones post.